Stock listing
Biostax Corp.
Selected listing: BTAX · OTC · USD · US
Biostax Corp. (OTC:BTAX), Health Technology. Latest release Feb 21, 2025: Biostax Corp Announces Voluntary Delisting from OTC Pink Market and SEC Deregistration
- Ticker
- OTC:BTAX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Biostax Corp.
The company focuses on innovative solutions in its sector, aiming to enhance its position in the industry. Biostax Corp. is committed to delivering value to its stakeholders through strategic initiatives and operational excellence.
Latest news from Biostax Corp.
Biostax Corp Announces Voluntary Delisting from OTC Pink Market and SEC Deregistration
February 21, 2025
Immune Therapeutics, Inc. Provides Shareholder Update on 14A
May 15, 2019
Immune Therapeutics welcomes Kevin Phelps to Board of Directors
January 9, 2019
Research on Lodonal (“LDN”) for HIV-related GI complications, and Inflammation featured in A&U Magazine
December 13, 2018
Immune Therapeutics Welcomes Amb. Jack Brewer to the Board of Directors
September 6, 2018